Carterra Ships Its First Ultra Biosensor Platform and Finishes 2024 with Double-digit Growth and Record Revenues
Read More
Webinar: Massively Parallel SPR-Based Fragment Screening on Ligand Arrays Webinar
Learn More
Vanderbilt University School of Medicine Basic Sciences Adds Carterra’s LSAXT Instrument to Speed Drug and Vaccine Research and Advance Patient Care
Read More
AI in Drug Discovery: High-throughput SPR Boosts Breakthroughs
Read More
Carterra unveils its most sensitive biosensor platform; Carterra Ultra™ ushers in a new frontier in fragment and small molecule drug discovery
Read More
2024 Carterra Symposia
Read More
Standard BioTools Purchases the Carterra® LSAXT System to Accelerate Data Delivery and Provide Greater Validation to SomaScan® Customers
Read More
Curia and Carterra Partner on Biologics Symposium to Further Biotechnology Research in the Pacific Northwest
Read More
IPA Acquires the Carterra LSA® Instrument to Enhance Antibody Discovery and Bolster Its AI Developments
Read More
Ordaōs Acquires the Carterra®LSA® Platform to Further Speed and Optimize Its Machine-Driven Drug Design System
Read More
